Inventor
CARMELO ROMANO
Inventor
US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
C07KPeptides19%
C12NMicroorganisms or enzymes19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
A01KAnimal husbandry9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms9%
C12YEnzymes4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
PatentTitleYear
12,582,104Mutant myocilin disease model and uses thereof202612,521,451CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy202612,396,444Mouse comprising a humanized TRKB locus202512,370,257Materials and methods of treating MHC-I-opathy risk haplotypes202512,157,891Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors202412,082,565Non-human animals models of retinoschisis202411,865,134Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors202411,845,989Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors202311,767,526Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors202311,492,392Polynucleotides encoding anti-C5 antibodies202211,479,602Methods of treating C5-associated diseases comprising administering anti-C5 antibodies202211,419,318Genetically modified rat comprising a humanized 2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to REGENERON PHARMA (12)· patent assignee history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (2)· patent assignee history
2022Patents assigned to REGENEREN PHARMACEUTICALS INC (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 12 | 2022–2026 |
| REGENERAN PHARMACEUTICALS INC | 2 | 2022 |
| REGENEREN PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 12 | 2022–2026 |